Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study L Piroth, J Cottenet, AS Mariet, P Bonniaud, M Blot, P Tubert-Bitter, ... The Lancet Respiratory Medicine 9 (3), 251-259, 2021 | 583 | 2021 |
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled … F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, J Poissy, ... The Lancet infectious diseases 22 (2), 209-221, 2022 | 365 | 2022 |
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 86 | 2021 |
CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS M Blot, M Jacquier, LS Aho Glele, G Beltramo, M Nguyen, P Bonniaud, ... Critical Care 24, 1-15, 2020 | 85 | 2020 |
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome M Blot, JB Bour, JP Quenot, A Bourredjem, M Nguyen, J Guy, S Monier, ... Journal of translational medicine 18, 1-14, 2020 | 69 | 2020 |
The value of open-source clinical science in pandemic response: lessons from ISARIC A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ... The Lancet infectious diseases 21 (12), 1623-1624, 2021 | 37 | 2021 |
Isolated anti-HBc: significance and management F Moretto, FX Catherine, C Esteve, M Blot, L Piroth Journal of clinical medicine 9 (1), 202, 2020 | 37 | 2020 |
Comparative review of imipenem/cilastatin versus meropenem A Salmon-Rousseau, C Martins, M Blot, M Buisson, S Mahy, P Chavanet, ... Médecine et Maladies Infectieuses 50 (4), 316-322, 2020 | 35 | 2020 |
Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID‐19 patients Y Yazdanpanah, French COVID Cohort Investigators and Study Group, ... Journal of Medical Virology 93 (4), 2149-2159, 2021 | 33 | 2021 |
Is there a need to widely prescribe antibiotics in patients hospitalized with COVID-19? F Moretto, T Sixt, H Devilliers, M Abdallahoui, I Eberl, T Rogier, M Buisson, ... International journal of infectious diseases 105, 256-260, 2021 | 31 | 2021 |
Are adipokines the missing link between obesity, immune response, and outcomes in severe COVID-19? M Blot, D Masson, M Nguyen, A Bourredjem, C Binquet, L Piroth International Journal of Obesity 45 (9), 2126-2131, 2021 | 28 | 2021 |
A leukocyte score to improve clinical outcome predictions in bacteremic pneumococcal pneumonia in adults M Blot, D Croisier, A Péchinot, A Vagner, A Putot, A Fillion, N Baudouin, ... Open forum infectious diseases 1 (2), ofu075, 2014 | 28 | 2014 |
Increasing burden of noninfectious lung disease in persons living with HIV: a 7-year study using the French nationwide hospital administrative database T Maitre, J Cottenet, G Beltramo, M Georges, M Blot, L Piroth, P Bonniaud, ... European Respiratory Journal 52 (3), 2018 | 27 | 2018 |
Mitochondrial alarmins are tissue mediators of ventilator-induced lung injury and ARDS S Grazioli, I Dunn-Siegrist, LA Pauchard, M Blot, PE Charles, J Pugin PloS one 14 (11), e0225468, 2019 | 25 | 2019 |
High plasma concentration of non-esterified polyunsaturated fatty acids is a specific feature of severe COVID-19 pneumonia M Nguyen, A Bourredjem, L Piroth, B Bouhemad, A Jalil, G Pallot, ... Scientific Reports 11 (1), 10824, 2021 | 24 | 2021 |
Alveolar SARS-CoV-2 viral load is tightly correlated with severity in COVID-19 ARDS M Blot, M Jacquier, C Manoha, L Piroth, PE Charles Clinical Infectious Diseases 72 (9), e446-e447, 2021 | 23 | 2021 |
How should a positive PCR test result for COVID-19 in an asymptomatic individual be interpreted and managed? C Esteve, FX Catherine, P Chavanet, M Blot, L Piroth Medecine et maladies infectieuses 50 (8), 633-638, 2020 | 19 | 2020 |
Should mild hypogammaglobulinemia be managed as severe hypogammaglobulinemia? A study of 389 patients with secondary hypogammaglobulinemia M Blot, P Boyer, M Samson, S Audia, H Devilliers, V Leguy, S Berthier, ... European Journal of Internal Medicine 25 (9), 837-842, 2014 | 18 | 2014 |
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19 F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, F Mentré, ... The Lancet Infectious Diseases 22 (6), 764-765, 2022 | 16 | 2022 |
Vitamin D supplementation, bone turnover, and inflammation in HIV-infected patients L Benguella, A Arbault, A Fillion, M Blot, C Piroth, D Denimal, L Duvillard, ... Medecine et maladies infectieuses 48 (7), 449-456, 2018 | 14 | 2018 |